Neonatal Abstinence Syndrome (NAS) Incidence and Health Care Costs in the United States, 2016
Authors: Gery Guy, Michele Bohm, MPH, Meghan Frey, MPH, Jean Ko
Publication Year: 2019
Last Updated: 2019-12-18
Journal: JAMA
Keywords: Neonatal Abstinence Syndrome, Opiods, Pediatrics, Infant Mortality
Abstract:
Neonatal abstinence syndrome (NAS) is a withdrawal syndrome primarily occurring in infants with in utero exposure to opioids. Neonatal abstinence syndrome is an important indicator of the immediate effect of the opioid crisis. Little is known about the physical and developmental health consequences of prenatal opioid exposure.1 Neonatal abstinence syndrome incidence rates have increased from 1.5 to 8.0 per 1000 hospital births in the United States from 2004 to 2014.2 Total hospital costs reached $316 million in 2012 and accounted for 4% of all neonatal intensive care unit hospital days nationwide in 2013.3,4 This study provides new national incidence and cost estimates for NAS in 2016.
File Download:
Source: Link to Original Article.
Source: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2756325?resultClick=1
